Peripheral Vascular Devices - Global Strategic Business Report

The global market for Peripheral Vascular Devices was valued at US$12.7 Billion in 2024 and is projected to reach US$16.0 Billion by 2030, growing at a CAGR of 4.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Peripheral Vascular Devices market.

Global Peripheral Vascular Devices Market - Key Trends and Drivers Summarized

Why Are Peripheral Vascular Devices Essential in Modern Medicine?

Peripheral vascular devices are critical tools in the diagnosis and treatment of diseases affecting the peripheral blood vessels, including arteries, veins, and lymphatic vessels outside of the heart and brain. These devices, which include stents, catheters, balloons, and filters, are used to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). The importance of these devices lies in their ability to restore proper blood flow, reduce the risk of complications, and improve patient outcomes. For instance, angioplasty balloons and stents are utilized to open narrowed or blocked arteries, enhancing blood circulation and preventing tissue damage. The development of minimally invasive techniques involving these devices has revolutionized vascular surgery, reducing recovery times and improving the quality of life for patients.

How Are Technological Advancements Shaping Peripheral Vascular Devices?

Technological advancements are significantly enhancing the functionality and efficacy of peripheral vascular devices. Innovations such as drug-eluting stents, which release medication to prevent restenosis, and bioresorbable stents, which gradually dissolve after restoring blood flow, represent significant breakthroughs in vascular treatment. Additionally, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are improving the precision of device placement and the assessment of vascular conditions. The integration of advanced materials, like shape-memory alloys and biocompatible polymers, is enhancing the durability and performance of these devices. Furthermore, the development of hybrid devices that combine multiple functions, such as drug delivery and mechanical support, is expanding the therapeutic options available to clinicians. These technological strides are making treatments safer, more effective, and less invasive.

What Are the Key Applications of Peripheral Vascular Devices?

Peripheral vascular devices have a wide range of applications across various medical disciplines. In interventional cardiology, these devices are used to treat PAD, which is characterized by the narrowing of peripheral arteries, typically in the legs, leading to pain and mobility issues. Endovascular treatments using balloons and stents help to reopen these arteries, restoring blood flow and alleviating symptoms. In vascular surgery, devices like grafts and endovascular aneurysm repair (EVAR) systems are essential for treating aneurysms, which are bulging or weakened areas in the vessel walls that can rupture if not managed properly. Additionally, peripheral vascular devices are crucial in managing venous diseases, such as DVT, where clot removal devices and filters prevent life-threatening complications like pulmonary embolism. The versatility and effectiveness of these devices in addressing various vascular conditions highlight their importance in contemporary medical practice.

What Factors Are Driving the Growth in the Peripheral Vascular Devices Market?

The growth in the peripheral vascular devices market is driven by several factors. One significant driver is the increasing prevalence of cardiovascular diseases and lifestyle-related conditions such as diabetes and hypertension, which heighten the risk of peripheral vascular disorders. Technological advancements that enhance the safety and efficacy of vascular devices are also propelling market growth, as they expand the range of treatable conditions and improve patient outcomes. Additionally, the aging global population is contributing to market expansion, as older adults are more susceptible to vascular diseases. The rising demand for minimally invasive procedures, which offer shorter recovery times and fewer complications compared to traditional surgeries, is further boosting the adoption of these devices. Moreover, increasing healthcare expenditure and improved access to advanced medical technologies in emerging markets are creating new opportunities for growth. These factors collectively ensure a robust growth trajectory for the peripheral vascular devices market, driven by the ongoing need for innovative and effective vascular treatments.

Report Scope

The report analyzes the Peripheral Vascular Devices market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Device Type (Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Other Device Types).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Angioplasty Stents segment, which is expected to reach US$9.1 Billion by 2030 with a CAGR of a 4.6%. The Angioplasty Balloon segment is also set to grow at 3.6% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $3.4 Billion in 2024, and China, forecasted to grow at an impressive 3.6% CAGR to reach $2.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Vascular Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Vascular Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Peripheral Vascular Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Laboratories, B. Braun Melsungen AG, BARD, A Becton, Dickinson Company, Biosensors International Group Ltd., Biotronik SE & Co. KG and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 38 companies featured in this Peripheral Vascular Devices market report include:

• Abbott Laboratories
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Biosensors International Group Ltd.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cordis Corporation
• iVascular S.L.U
• Medtronic PLC
• Terumo Corporation

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry